These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 649815)

  • 21. Pharmacologic influences on mating behavior in the male rat. Effects of d-amphetamine, LSD-25, strychnine, nicotine and various anticholinergic agents.
    Bignami G
    Psychopharmacologia; 1966; 10(1):44-58. PubMed ID: 4383171
    [No Abstract]   [Full Text] [Related]  

  • 22. Modification of the effects of LSD-25, d-amphetamine and tryptamine on electrically evoked responses in the visual system by methiothepin and octoclothepin.
    Moore RH; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):66-73. PubMed ID: 581833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed auditory feedback in schizophrenia and LSD-induced state.
    Vinar O; Bastecký J; Borovicková B; Zichová M; Malac V
    Act Nerv Super (Praha); 1965 Aug; 7(3):302-3. PubMed ID: 5882134
    [No Abstract]   [Full Text] [Related]  

  • 24. The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
    Vaupel DB; Nozaki M; Martin WR; Bright LD; Morton EC
    Life Sci; 1979 Jun; 24(26):2427-31. PubMed ID: 481115
    [No Abstract]   [Full Text] [Related]  

  • 25. LSD and d-amphetamine effects on fixed interval responding in the rat.
    Ksir C; Nelson S
    Pharmacol Biochem Behav; 1977 Mar; 6(3):269-72. PubMed ID: 857253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual effects of LSD on ego functioning: an exploratory study with the Rorschach test.
    Axelrod P; Kessel P
    Psychol Rep; 1972 Oct; 31(2):547-50. PubMed ID: 5081343
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of the pigment screening of the frog retina following administration of neuroactive drugs.
    Kemali M; Milici N; Kemali D
    Exp Eye Res; 1983 Nov; 37(5):493-8. PubMed ID: 6142827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of lysergic acid diethylamide (LSD-25) on impulse control.
    ARONSON H; KLEE GD
    J Nerv Ment Dis; 1960 Dec; 131():536-9. PubMed ID: 13684462
    [No Abstract]   [Full Text] [Related]  

  • 32. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs and the discrimination of duration.
    Altman JL; Appel JB; McGowan WT
    Psychopharmacology (Berl); 1979 Jan; 60(2):183-8. PubMed ID: 106429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.
    Tagliazucchi E; Roseman L; Kaelen M; Orban C; Muthukumaraswamy SD; Murphy K; Laufs H; Leech R; McGonigle J; Crossley N; Bullmore E; Williams T; Bolstridge M; Feilding A; Nutt DJ; Carhart-Harris R
    Curr Biol; 2016 Apr; 26(8):1043-50. PubMed ID: 27085214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.
    Jacobs BL; Trulson ME; Stern WC
    Brain Res; 1977 Aug; 132(2):301-14. PubMed ID: 19128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
    Iriye TT; Kuna A; Simmonds FA
    Biochem Pharmacol; 1965 Jul; 14(7):1169-71. PubMed ID: 5892600
    [No Abstract]   [Full Text] [Related]  

  • 38. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 39. Current views on the psychophysiology of hypnosis.
    Mellett P
    Br J Hosp Med; 1980 May; 23(5):441, 444-6. PubMed ID: 7388200
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative phenomenology of experimental mental alterations after application of LSD, benactyzine and phenmetrzine.
    Dolezal V; Hausner M
    Act Nerv Super (Praha); 1968 Oct; 10(3):280-2. PubMed ID: 5702526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.